These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 32927853)
81. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. Jordan PM; Werz O FEBS J; 2022 Jul; 289(14):4212-4227. PubMed ID: 34741578 [TBL] [Abstract][Full Text] [Related]
82. Resolution of inflammation: An organizing principle in biology and medicine. Panigrahy D; Gilligan MM; Serhan CN; Kashfi K Pharmacol Ther; 2021 Nov; 227():107879. PubMed ID: 33915177 [TBL] [Abstract][Full Text] [Related]
83. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain. Tao X; Lee MS; Donnelly CR; Ji RR Neurotherapeutics; 2020 Jul; 17(3):886-899. PubMed ID: 32696274 [TBL] [Abstract][Full Text] [Related]
84. G-Protein Coupled Receptors Involved in the Resolution of Inflammation: Ligands and Therapeutic Perspectives. Mastromarino M; Lacivita E; Colabufo NA; Leopoldo M Mini Rev Med Chem; 2020; 20(20):2090-2103. PubMed ID: 32682373 [TBL] [Abstract][Full Text] [Related]
85. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711 [TBL] [Abstract][Full Text] [Related]
86. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Yang R; Chiang N; Oh SF; Serhan CN Curr Protoc Immunol; 2011 Nov; Chapter 14():Unit 14.26. PubMed ID: 22048801 [TBL] [Abstract][Full Text] [Related]
87. COVID-19 and cancer: start the resolution! Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921 [TBL] [Abstract][Full Text] [Related]
88. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair. Tiberi M; Chiurchiù V Front Cell Neurosci; 2021; 15():673549. PubMed ID: 33981203 [TBL] [Abstract][Full Text] [Related]
89. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Chiang N; Serhan CN Mol Aspects Med; 2017 Dec; 58():114-129. PubMed ID: 28336292 [TBL] [Abstract][Full Text] [Related]
90. Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators. Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):157-63. PubMed ID: 19008087 [TBL] [Abstract][Full Text] [Related]
91. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Weiss GA; Troxler H; Klinke G; Rogler D; Braegger C; Hersberger M Lipids Health Dis; 2013 Jun; 12():89. PubMed ID: 23767972 [TBL] [Abstract][Full Text] [Related]
93. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Serhan CN; Chiang N; Van Dyke TE Nat Rev Immunol; 2008 May; 8(5):349-61. PubMed ID: 18437155 [TBL] [Abstract][Full Text] [Related]
94. Resolution of Inflammation in Retinal Disorders: Briefly the State. Trotta MC; Gesualdo C; Petrillo F; Lepre CC; Della Corte A; Cavasso G; Maggiore G; Hermenean A; Simonelli F; D'Amico M; Rossi S Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562891 [TBL] [Abstract][Full Text] [Related]
95. Chronic Inflammation in PCOS: The Potential Benefits of Specialized Pro-Resolving Lipid Mediators (SPMs) in the Improvement of the Resolutive Response. Regidor PA; Mueller A; Sailer M; Gonzalez Santos F; Rizo JM; Egea FM Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396555 [TBL] [Abstract][Full Text] [Related]
96. Expert consensus report on lipid mediators: Role in resolution of inflammation and muscle preservation. Serhan CN; Bäck M; Chiurchiù V; Hersberger M; Mittendorfer B; Calder PC; Waitzberg DL; Stoppe C; Klek S; Martindale RG; FASEB J; 2024 May; 38(10):e23699. PubMed ID: 38805158 [TBL] [Abstract][Full Text] [Related]
97. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS. Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224 [TBL] [Abstract][Full Text] [Related]
98. Prostanoids and Resolution of Inflammation - Beyond the Lipid-Mediator Class Switch. Schmid T; Brüne B Front Immunol; 2021; 12():714042. PubMed ID: 34322137 [TBL] [Abstract][Full Text] [Related]
99. The roles of special proresolving mediators in pain relief. Zhang LY; Jia MR; Sun T Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307 [TBL] [Abstract][Full Text] [Related]
100. Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic. Kumar V; Yasmeen N; Chaudhary AA; Alawam AS; Al-Zharani M; Suliman Basher N; Harikrishnan S; Goud MD; Pandey A; Lakhawat SS; Sharma PK Front Mol Biosci; 2023; 10():1104577. PubMed ID: 36825200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]